No Data
No Data
ResMed Shares Higher as Company 'Turns the GLP Threat Into an Opportunity': Fundie
ResMed CDI (ASX: RMD) shares closed at $32.80 apiece on Tuesday, up 1.14% for the day.
Buy, Hold or Sell These 3 ASX 200 Healthcare Shares: Experts
ASX 200 healthcare shares are in the red with the rest of the market on Friday.
2 of the Best ASX 200 Blue Chip Shares to Buy in May
There are plenty of blue chip shares on the ASX 200 index. But which ones could be buys in May?Let's take a look at two shares that are rated as best buys by a couple of leading brokers right now.
3 Reasons ResMed Shares 'Are Just Too Cheap!'
The Resmed CDI (ASX: RMD) share price has risen 46% over the last six months, and a fund manager reckons there are more gains to come.
AU Evening Wrap: ASX Rally Late to Close Flat; Fletcher Plummets 11%
Consumer and health stocks were the best performers as the benchmark index rallied from almost 0.4% down over the last hour of Monday's session.
Resmed Share Price Higher Despite CEO Hitting Sell on 14,683 Shares
It's been a pleasant Friday for the S&P/ASX 200 Index (ASX: XJO) and most ASX 200 shares today. At the close of trading, the ASX 200 had gained 0.35% and was back above 7,740 points.
No Data